Bob Repella
CEO, Co-Founder,
Artasome Therapeutics
United States
Summary of Previous Experience and Qualifications (over 40 years):
Board Member, Biohaven Pharmaceuticals
CEO, Harmony Biosciences
CSL Behring: EVP, Global Operations and Medical Affairs
Vanda Pharmaceuticals, Chief Commericial Officer
Cephalon, Sr. VP, Commerical Operations
Wyeth Pharnaceuticals, EVP, Biosciences BU and Global Operations (last role, total time 16 years at Wyeth)
Prior ten years: Lilly, Merck, JNJ
Suffix
RPh
Sessions
-
10-Feb-2025Artasome Therapeutics
)
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}